Skip to main content

Advertisement

ADVERTISEMENT

News

News
04/05/2021
Hancock Jaffe Laboratories, Inc., a developer of medical devices that restore cardiac and vascular health, today announced that the U.S. Food and Drug Administration (FDA) has approved the company’s Investigational Device Exemption (IDE)...
Hancock Jaffe Laboratories, Inc., a developer of medical devices that restore cardiac and vascular health, today announced that the U.S. Food and Drug Administration (FDA) has approved the company’s Investigational Device Exemption (IDE)...
Hancock Jaffe Laboratories,...
04/05/2021
Vascular Disease Management
News
03/17/2021
Transit Scientific announced it received CE Mark approval in the European Union for its non-tapered metal alloy XO Cross® Microcatheter platform.
Transit Scientific announced it received CE Mark approval in the European Union for its non-tapered metal alloy XO Cross® Microcatheter platform.
Transit Scientific announced it...
03/17/2021
Vascular Disease Management

Advertisement

News
03/04/2021
Medtronic today announced the launch of IN.PACT AV drug-coated balloon (DCB) in Japan. IN.PACT AV DCB is indicated for the treatment of obstructive lesions up to 100 mm in length in the native arteriovenous (AV) dialysis fistulae in patients...
Medtronic today announced the launch of IN.PACT AV drug-coated balloon (DCB) in Japan. IN.PACT AV DCB is indicated for the treatment of obstructive lesions up to 100 mm in length in the native arteriovenous (AV) dialysis fistulae in patients...
Medtronic today announced the...
03/04/2021
Vascular Disease Management
News
03/02/2021
Cook Medical’s Zenith® Fenestrated+ Endovascular Graft (ZFEN+) product has received Breakthrough Device designation from the US Food and Drug Administration (FDA). This designation is granted for devices that have the potential to provide...
Cook Medical’s Zenith® Fenestrated+ Endovascular Graft (ZFEN+) product has received Breakthrough Device designation from the US Food and Drug Administration (FDA). This designation is granted for devices that have the potential to provide...
Cook Medical’s Zenith®...
03/02/2021
Vascular Disease Management
News
02/16/2021
Trial to provide first clinical experience in fistula surveillance for early detection and prediction of fistula stenosis
Trial to provide first clinical experience in fistula surveillance for early detection and prediction of fistula stenosis
Trial to provide first clinical...
02/16/2021
Vascular Disease Management

Advertisement

News
02/10/2021
Ruptured abdominal aortic aneurysms (rAAA) are responsible for nearly 2% of all deaths in U.S. men over the age of 65. Endovascular aneurysm repair (EVAR) has emerged as a newer and less invasive alternative to open repair for rAAA, and...
Ruptured abdominal aortic aneurysms (rAAA) are responsible for nearly 2% of all deaths in U.S. men over the age of 65. Endovascular aneurysm repair (EVAR) has emerged as a newer and less invasive alternative to open repair for rAAA, and...
Ruptured abdominal aortic...
02/10/2021
Vascular Disease Management
News
02/05/2021
One-year results from BIOLUX AV published and presented at LINC 2021 on use of DCB angioplasty for hemodialysis access.
One-year results from BIOLUX AV published and presented at LINC 2021 on use of DCB angioplasty for hemodialysis access.
One-year results from BIOLUX AV...
02/05/2021
Vascular Disease Management
News
02/03/2021
BATON ROUGE- Cardiovascular Institute of the South (CIS) electrophysiologist, Dr. Robert Drennan, is the first in Baton Rouge, and second in the state, to implant the Gallant™ Implantable Cardioverter-Defibrillator (ICD), the...
BATON ROUGE- Cardiovascular Institute of the South (CIS) electrophysiologist, Dr. Robert Drennan, is the first in Baton Rouge, and second in the state, to implant the Gallant™ Implantable Cardioverter-Defibrillator (ICD), the...
BATON ROUGE- Cardiovascular...
02/03/2021
Vascular Disease Management

Advertisement

News
02/03/2021
Transit Scientific today announced the close of its Series A financing round. The round was led by a large multinational investor and joined by previous seed investors. Transit Scientific achieved FDA clearances and multi-center, multi-user,...
Transit Scientific today announced the close of its Series A financing round. The round was led by a large multinational investor and joined by previous seed investors. Transit Scientific achieved FDA clearances and multi-center, multi-user,...
Transit Scientific today...
02/03/2021
Vascular Disease Management
News
02/02/2021
BATON ROUGE- Cardiovascular Institute of the South (CIS) interventional cardiologist, Dr. Niksad Abraham, is the first at Baton Rouge General to use the CardioMEMS™ HF System to treat heart failure.
BATON ROUGE- Cardiovascular Institute of the South (CIS) interventional cardiologist, Dr. Niksad Abraham, is the first at Baton Rouge General to use the CardioMEMS™ HF System to treat heart failure.
BATON ROUGE- Cardiovascular...
02/02/2021
Vascular Disease Management

Advertisement